| Business Summary | | Nanogen,
Inc.
markets
its
NanoChip
Molecular
Biology
Workstation
system
to
scientists
and
genomics
laboratories,
setting
new
standards
for
SNP
scoring.
In
addition,
Nanogen
is
developing
a
series
of
electronics-based
products
to
help
researchers
and
clinical
healthcare
providers
accelerate
their
practical
understanding
and
use
of
genomic
information.
The
products
introduced
and
under
development
are
intended
to
provide
quick
and
accurate
analysis
of
DNA,
RNA
and
proteins,
and
may
eventually
"bridge"
the
gap
between
the
research
and
clinical
settings.
The
Nanogen
system
is
intended
for
research
use
only
and
not
for
use
in
diagnostic
procedures. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Nanogen,
Inc.
integrates
advanced
microelectronics
and
molecular
biology
into
a
platform
technology
with
applications
in
the
fields
of
medical
diagnostics,
genetic
testing,
genomics,
biomedical
research,
and
drug
discovery.
For
the
six
months
ended
6/30/01,
revenues
rose
21%
to
$5.7
million.
Net
loss
totaled
$18
million,
up
from
$7.8
million.
Results
reflect
an
increase
in
sponsored
research
programs
and
government
grants,
offset
by
$5.5
million
in
litigation
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Howard Birndorf, 50 Chairman | $983K | V. Randy White, Ph.D., 53 CEO,
Director | -- | Kieran Gallahue, 36 Pres | 507K | Gerard Wills, 48 CFO,
VP, Treasurer | -- | Clare Bromley, III, 51 Sr.
VP of Sales and Marketing | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|